ArticleACS medicinal chemistry letters2025

Optimizing Linezolid: Transforming It into a Selective MAO-B Inhibitor via a Toxicity-to-Activity Optimization Approach.

Mayur S Dhangar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.